Together, the expression of the components of the Ku70-mediated Ras-ERK-Cdc25A-CDK1 pathway could serve as a potential biomarker in predicting the survival and prognosis of patients with intestinal cancer. This evidence concerns the gene MAPK1 and intestinal cancer.